- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Safety Data Sheets
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Diversity, Equity, and Inclusion Everyone has something to offer
- EHS Governance
- Environmental Sustainability Our responsiblity to the environment
- Global Impact Meeting urgent needs worldwide
- Health & Safety
- Human Rights Furthering dignity and worth
- Intellectual Property The benefits of fair competition
- Patient Advocacy & Engagement Putting Patients First
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
Our Quality Policy
Our Corporate Quality Policy describes how we ensure the delivery of safe and effective drug, biologic, consumer, medical device and combination products and meet regulatory requirements and other relevant standards and guidelines. It provides a systematic approach designed to ensure we meet our commitment to patients and it defines the elements of our Quality Management System (QMS) for regulated activities.
Our commitment to developing, manufacturing, and delivering safe and effective products to patients includes:
- Maintaining an effective QMS within and across divisions
- Complying with all applicable quality regulations, codes and standards
- Maintaining a quality and integrity focused culture in which each person is required to carry out their responsibilities with proper regard for quality and to ensure the highest priority is placed on the safety and efficacy of our products, the safety of our patients, the integrity of data, and the trustworthiness of interactions with our Stakeholders
- Reporting and addressing quality issues, risks and concerns through appropriate corporate or divisional processes.
Elements of the Pfizer Quality Management System
- Quality & Integrity Culture
A robust culture of integrity and accountability is in place in which quality and compliance are seamlessly integrated into day-to-day business processes and activities to help ensure the highest priority is placed on the safety of our patients, quality of our products, integrity of our data, and Pfizer’s reputation.
- Governance & Organization
Senior leaders with the appropriate accountability and decision-making authority periodically review the performance of the QMS to ensure that it continues to fulfill quality objectives, remains aligned with the strategic direction of the organization, is supported by appropriate resources, and provides a pathway for escalation of quality, safety and compliance issues and risks.
- Risk Management
Known and emerging quality, safety and compliance risks are identified, assessed, escalated, and mitigated.
- Processes & Procedures
Processes, policies and procedures and any associated changes are managed in a controlled manner, commensurate with the level of risk.
- Training & Qualification
All individuals who perform work for, or on behalf of, Pfizer have the appropriate education, training, skills, qualifications, and experience to carry out their work competently, in accordance with all applicable laws, regulations, and Pfizer policies and procedures.
- Oversight & Monitoring
Programs and plans are in place for monitoring process performance, product quality, safety and compliance with applicable regulations and Pfizer policies to ensure a state of control is maintained.
- Issue Management & CAPA
Quality issues are investigated, with effective corrective and preventative actions (CAPA) implemented. Mechanisms are in place for timely escalation of critical quality, safety, and compliance issues.
- Third Party Management
Controls are in place to manage risks that originate from, or are related to, dependence on external entities, including third parties conducting work on Pfizer's behalf and other partnership arrangements, designed to ensure compliance with all applicable regulations and Pfizer policies.
How Drugs Are Made
Today's medicines have, on average, taken 12 years to go from inception to market. We believe that with dedication, creativity, and science, we can significantly reduce that time.
Clinical Trials